chlorine has been researched along with montelukast in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Allard, B; Ano, S; Hamamoto, Y; Martin, JG; McGovern, TK; O'Sullivan, M | 1 |
| Au, SC; Chow, AW; Ko, WH; Lau, WK | 1 |
2 other study(ies) available for chlorine and montelukast
| Article | Year |
|---|---|
Montelukast reduces inhaled chlorine triggered airway hyperresponsiveness and airway inflammation in the mouse.
Topics: Acetates; Animals; Anti-Inflammatory Agents; Antibodies, Monoclonal; Bronchoalveolar Lavage Fluid; Cell Line; Chlorine; Cyclopropanes; Cytokines; Irritants; Leukotriene Antagonists; Lung; Male; Mice, Inbred BALB C; NF-E2-Related Factor 2; Quinolines; Receptors, Interleukin-6; Respiratory Hypersensitivity; Sulfides | 2017 |
Differential inhibitory effects of CysLT(1) receptor antagonists on P2Y(6) receptor-mediated signaling and ion transport in human bronchial epithelia.
Topics: Acetates; Bronchi; Calcium; Cell Line; Chlorides; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Cyclopropanes; Electric Conductivity; Enzyme Activation; Gene Expression Regulation; Guanine Nucleotide Exchange Factors; Humans; Ion Transport; Leukotriene Antagonists; Quinolines; Receptors, Leukotriene; Receptors, Purinergic P2; Respiratory Mucosa; Signal Transduction; Sulfides; Uridine Diphosphate | 2011 |